Bristol Myers Squibb paid more than $515 million over illegal drug marketing and pricing allegations
Company: Bristol Myers Squibb
Summary
Bristol-Myers Squibb and a subsidiary agreed to pay more than $515 million to resolve federal allegations involving illegal remuneration to healthcare providers, off-label promotion of Abilify, and drug-pricing practices that caused false claims to government healthcare programs. Source: https://www.justice.gov/archive/opa/pr/2007/September/07_civ_782.html